Sebaceous carcinoma: controversies and their evidence for clinical practice

[1]  P. Gibson,et al.  Carboplatin and Pembrolizumab Chemoimmunotherapy Achieves Remission in Recurrent, Metastatic Sebaceous Carcinoma. , 2018, Ophthalmic plastic and reconstructive surgery.

[2]  M. Tetzlaff,et al.  Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients , 2018, British Journal of Ophthalmology.

[3]  J. Wargo,et al.  High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma , 2018, Oncoimmunology.

[4]  Jianlin Yuan,et al.  Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma , 2018, Journal of Immunotherapy for Cancer.

[5]  R. Sandford,et al.  Evaluation of universal immunohistochemical screening of sebaceous neoplasms in a service setting , 2018, Clinical and experimental dermatology.

[6]  C. Chelala,et al.  MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma , 2018, Scientific Reports.

[7]  E. O’Toole,et al.  Analysis of hedgehog signaling in periocular sebaceous carcinoma , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

[8]  M. Sawyer,et al.  Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A. Gesierich,et al.  Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma , 2017, The New England journal of medicine.

[10]  B. Esmaeli,et al.  Prognostic Value of the Staging System for Eyelid Tumors in the 7th Edition of the American Joint Committee on Cancer Staging Manual. , 2017, Ophthalmic plastic and reconstructive surgery.

[11]  E. Hurst,et al.  Sebaceous Carcinoma Treated With Mohs Micrographic Surgery , 2017, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[12]  S. Meehan,et al.  Universal immunohistochemical screening of sebaceous neoplasms for Muir-Torre syndrome: Putting the cart before the horse? , 2016, Journal of the American Academy of Dermatology.

[13]  P. Ram,et al.  Next‐generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma , 2016, The Journal of pathology.

[14]  T. Tabone,et al.  Circumscribed sebaceous neoplasms: a morphological, immunohistochemical and molecular analysis. , 2016, Pathology.

[15]  S. Kaliki,et al.  Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification , 2016, International Ophthalmology.

[16]  S. Kaliki,et al.  Neoadjuvant Systemic Chemotherapy in the Management of Extensive Eyelid Sebaceous Gland Carcinoma: A study of 10 Cases , 2016, Ophthalmic plastic and reconstructive surgery.

[17]  Vivian T. Yin,et al.  Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAs. , 2015, JAMA ophthalmology.

[18]  Y. Xu,et al.  Unusual presentation of metastatic sebaceous carcinoma and its response to chemotherapy: is genotyping a right answer for guiding chemotherapy in rare tumours? , 2015, Current oncology.

[19]  S. Tagliolatto,et al.  Sebaceous hyperplasia: systemic treatment with isotretinoin* , 2015, Anais brasileiros de dermatologia.

[20]  V. White,et al.  Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance? , 2014, Acta ophthalmologica.

[21]  P. Aung,et al.  Extraocular sebaceous carcinoma in situ: report of three cases and review of the literature , 2014, Journal of cutaneous pathology.

[22]  M. Heckman,et al.  A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndrome , 2014, Genetics in Medicine.

[23]  Michelle T. Sun,et al.  Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes , 2013, British Journal of Ophthalmology.

[24]  E. Lentsch,et al.  Population‐based analysis of prognostic indicators in sebaceous carcinoma of the head and neck , 2013, The Laryngoscope.

[25]  Rakesh Kumar,et al.  Sentinel Lymph Node Biopsy in Malignant Eyelid Tumor: Hybrid Single Photon Emission Computed Tomography/Computed Tomography and Dual Dye Technique. , 2013, American journal of ophthalmology.

[26]  B. Esmaeli,et al.  Sentinel Lymph Node Biopsy for Eyelid and Conjunctival Tumors: What Have We Learned in the Past Decade? , 2013, Ophthalmic plastic and reconstructive surgery.

[27]  Bonnie Lee,et al.  Sebaceous neoplasms with mismatch repair protein expressions and the frequency of co-existing visceral tumors. , 2012, Journal of the American Academy of Dermatology.

[28]  Nitin A. Pagedar,et al.  Epidemiology of sebaceous carcinoma of the head and neck: Implications for lymph node management , 2012, Head & neck.

[29]  K. Prabhash,et al.  Sebaceous carcinoma and systemic chemotherapy , 2012, Indian Journal of Medical and Paediatric Oncology.

[30]  A. D. Pereira,et al.  Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome , 2012, Familial Cancer.

[31]  N. Shukla,et al.  Locally Advanced Sebaceous Cell Carcinoma (T3) of Eyelid: Incidence and Pattern of Nodal Metastases and Combined Modality Management Approach , 2012, Orbit.

[32]  B. Esmaeli,et al.  American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. , 2012, Ophthalmology.

[33]  K. Whitehead,et al.  The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir–Torre syndrome , 2011, British Journal of Ophthalmology.

[34]  R. Weber,et al.  Management of Perineural Invasion in Sebaceous Carcinoma of the Eyelid , 2011, Ophthalmic plastic and reconstructive surgery.

[35]  D. Horowitz,et al.  Isotretinoin as monotherapy for sebaceous hyperplasia. , 2010, Journal of drugs in dermatology : JDD.

[36]  A. Lazar,et al.  Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma , 2010, Journal of cutaneous pathology.

[37]  M. Ross,et al.  Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. , 2009, Ophthalmology.

[38]  Breno Dauster,et al.  Sebaceous Carcinoma of the Penis , 2009, Urologia Internationalis.

[39]  S. Uffer,et al.  Clinicopathological Features of Eyelid Skin Tumors. A Retrospective Study of 5504 Cases and Review of Literature , 2009, The American Journal of dermatopathology.

[40]  R. Mcgoldrick,et al.  Should Extraocular Sebaceous Carcinoma Be Investigated Using Sentinel Node Biospy? , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[41]  J. Fraumeni,et al.  Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms , 2008, Cancer.

[42]  W. Frankel,et al.  The frequency of Muir-Torre syndrome among Lynch syndrome families. , 2008, Journal of the National Cancer Institute.

[43]  M. Ross,et al.  Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. , 2007, Archives of otolaryngology--head & neck surgery.

[44]  D. Cassarino,et al.  Distinction of Benign Sebaceous Proliferations From Sebaceous Carcinomas by Immunohistochemistry , 2006, The American Journal of dermatopathology.

[45]  C. Shields,et al.  Sebaceous carcinoma of the ocular region: a review. , 2005, Survey of ophthalmology.

[46]  H. Grossniklaus.  Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Nijhawan N, Ross M, Diba R, Gutstein BF, Ahmadi MA, Esmaeli B.* Ophthalmol Plas Recon Surg 2004;20:291–295 , 2004 .

[47]  M. Ross,et al.  Experience With Sentinel Lymph Node Biopsy for Eyelid and Conjunctival Malignancies at a Cancer Center , 2004, Ophthalmic plastic and reconstructive surgery.

[48]  F. Bassetto,et al.  Biological Behavior of the Sebaceous Carcinoma of the Head , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[49]  Z. Gatalica,et al.  Loss of mismatch repair proteins in sebaceous gland tumors , 2003, Journal of cutaneous pathology.

[50]  M. Ross,et al.  Feasibility of Preoperative Lymphoscintigraphy for Identification of Sentinel Lymph Nodes in Patients With Conjunctival and Periocular Skin Malignancies , 2003, Ophthalmic plastic and reconstructive surgery.

[51]  Matthew W. Wilson,et al.  Sentinel Node Biopsy for Orbital and Ocular Adnexal Tumors , 2001, Ophthalmic plastic and reconstructive surgery.

[52]  V. Bataille,et al.  An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. , 2001, The Journal of investigative dermatology.

[53]  Charis Eng,et al.  Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations inMSH2 and MLH1 , 2000, Journal of medical genetics.

[54]  F. Codère,et al.  Sebaceous carcinoma of the eyelid in an immunocompromised patient with Muir-Torre syndrome. , 1995, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[55]  K. Sueishi,et al.  The diagnostic use of low molecular weight keratin expression in sebaceous carcinoma. , 1993, Pathology, research and practice.

[56]  B. Esmaeli,et al.  Change in Eyelid Carcinoma T Category With Use of the 8th Versus 7th Edition of the American Joint Committee on Cancer: Cancer Staging Manual. , 2019, Ophthalmic plastic and reconstructive surgery.

[57]  F. Jakobiec,et al.  Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin. , 2014, American journal of ophthalmology.

[58]  Rakesh Kumar,et al.  Sentinel lymph node biopsy in malignant eyelid tumor: hybrid single photon emission computed tomography/computed tomography and dual dye technique. , 2013, American journal of ophthalmology.

[59]  B. Esmaeli,et al.  Positive sentinel node in sebaceous carcinoma of the eyelid. , 2011, Ophthalmic plastic and reconstructive surgery.

[60]  L. Wilson,et al.  A retrospective review of 1349 cases of sebaceous carcinoma , 2009, Cancer.

[61]  M. Ross,et al.  Erratum: Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center (Ophthalmic Plastic and Reconstructive Surgery (2004) 20 (291-295)) , 2005 .

[62]  Y. Shimosato,et al.  Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.